Celularity Receives Nasdaq Delisting Notice for Failing $35M Market Value Requirement
CELU is trading near its 52-week low of $0.667 (6.9% above the low) on light trading volume (0.3× avg).
Summary
Celularity Inc. faces potential delisting from Nasdaq after failing to meet the $35 million minimum Market Value of Listed Securities requirement, with a compliance deadline of December 7, 2026.
Key Events · Legal and Risk Events · CELU
-
Delisting Notice Received
Celularity Inc. received a notice from Nasdaq on June 9, 2026, for non-compliance with the minimum Market Value of Listed Securities (MVLS) rule.
-
Non-Compliance Reason
The company's MVLS has been below the required $35 million for 30 consecutive business days.
-
Compliance Deadline
Celularity has 180 calendar days, until December 7, 2026, to regain compliance by having its MVLS meet or exceed $35 million for at least 10 consecutive business days.
-
Potential Actions
The company is evaluating options to regain compliance, including monitoring its market value and potentially increasing stockholders' equity.
Analysis · CELU · Life Sciences
Celularity Inc. has received a notice from Nasdaq indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) requirement. The company's MVLS has been below $35 million for 30 consecutive business days. This is a critical development as failure to regain compliance by December 7, 2026, could lead to delisting, significantly impacting the company's ability to raise capital and investor confidence.
At the time of this filing, CELU was trading at $0.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $0.67 to $4.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.